Rtw Investments as of June 30, 2024
Portfolio Holdings for Rtw Investments
Rtw Investments holds 68 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Madrigal Pharmaceuticals (MDGL) | 8.3 | $537M | 1.9M | 280.16 | |
Rocket Pharmaceuticals (RCKT) | 5.9 | $381M | 18M | 21.53 | |
Axsome Therapeutics (AXSM) | 5.8 | $373M | 4.6M | 80.50 | |
Avidity Biosciences Ord (RNA) | 5.6 | $360M | 8.8M | 40.85 | |
Argenx Se Sponsored Adr (ARGX) | 4.4 | $281M | 654k | 430.04 | |
Natera (NTRA) | 4.3 | $281M | 2.6M | 108.29 | |
Merus N V (MRUS) | 3.8 | $247M | 4.2M | 59.17 | |
Insmed Com Par $.01 (INSM) | 3.8 | $244M | 3.6M | 67.00 | |
Ptc Therapeutics I (PTCT) | 3.5 | $226M | 7.4M | 30.58 | |
Dyne Therapeutics (DYN) | 3.5 | $225M | 6.4M | 35.29 | |
ACADIA Pharmaceuticals (ACAD) | 3.4 | $223M | 14M | 16.25 | |
Bruker Corporation (BRKR) | 3.4 | $220M | 3.4M | 63.81 | |
Masimo Corporation (MASI) | 2.9 | $184M | 1.5M | 125.94 | |
Protagonist Therapeutics (PTGX) | 2.8 | $183M | 5.3M | 34.65 | |
Alkermes SHS (ALKS) | 2.6 | $170M | 7.1M | 24.10 | |
Immunocore Hldgs Ads (IMCR) | 2.6 | $165M | 4.9M | 33.89 | |
Cytokinetics Com New (CYTK) | 2.3 | $147M | 2.7M | 54.18 | |
Ultragenyx Pharmaceutical (RARE) | 2.1 | $134M | 3.3M | 41.10 | |
Penumbra (PEN) | 2.1 | $134M | 742k | 179.97 | |
Akero Therapeutics (AKRO) | 2.0 | $127M | 5.4M | 23.46 | |
Establishment Labs Holdings Ord (ESTA) | 1.9 | $122M | 2.7M | 45.44 | |
Immatics SHS (IMTX) | 1.8 | $116M | 10M | 11.62 | |
RadNet (RDNT) | 1.7 | $109M | 1.9M | 58.92 | |
Apogee Therapeutics (APGE) | 1.7 | $107M | 2.7M | 39.35 | |
Tarsus Pharmaceuticals (TARS) | 1.4 | $93M | 3.4M | 27.18 | |
Intuitive Surgical Com New (ISRG) | 1.4 | $90M | 203k | 444.85 | |
Arvinas Ord (ARVN) | 1.2 | $79M | 3.0M | 26.62 | |
Spyre Therapeutics Com New (SYRE) | 1.2 | $77M | 3.3M | 23.51 | |
Cargo Therapeutics (CRGX) | 1.0 | $67M | 4.1M | 16.42 | |
Urogen Pharma (URGN) | 0.9 | $60M | 3.6M | 16.78 | |
Sage Therapeutics (SAGE) | 0.9 | $60M | 5.5M | 10.86 | |
89bio (ETNB) | 0.9 | $59M | 7.4M | 8.01 | |
Stoke Therapeutics (STOK) | 0.9 | $57M | 4.2M | 13.51 | |
Health Sciences Acq Corp 2 (OBIO) | 0.7 | $46M | 5.6M | 8.15 | |
Glaukos (GKOS) | 0.7 | $46M | 386k | 118.35 | |
Cg Oncology (CGON) | 0.7 | $42M | 1.3M | 31.57 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.7 | $42M | 19M | 2.24 | |
Neurogene (NGNE) | 0.6 | $39M | 1.1M | 36.39 | |
Gh Research Ordinary Shares (GHRS) | 0.6 | $39M | 3.3M | 11.66 | |
Vericel (VCEL) | 0.6 | $37M | 801k | 45.88 | |
Fulcrum Therapeutics (FULC) | 0.6 | $36M | 5.8M | 6.20 | |
Cullinan Oncology (CGEM) | 0.3 | $18M | 1.1M | 17.44 | |
Dianthus Therapeutics (DNTH) | 0.3 | $17M | 667k | 25.88 | |
Roivant Sciences SHS (ROIV) | 0.2 | $15M | 1.5M | 10.57 | |
Lenz Therapeutics (LENZ) | 0.2 | $15M | 863k | 17.29 | |
Tempus Ai Cl A (TEM) | 0.2 | $14M | 400k | 35.00 | |
Kyverna Therapeutics (KYTX) | 0.2 | $14M | 1.9M | 7.50 | |
Essa Pharma Com New (EPIX) | 0.2 | $12M | 2.3M | 5.26 | |
Replimune Group (REPL) | 0.2 | $10M | 1.1M | 9.00 | |
10x Genomics Cl A Com (TXG) | 0.2 | $9.8M | 503k | 19.45 | |
Tourmaline Bio (TRML) | 0.1 | $9.5M | 742k | 12.86 | |
Miragen Therapeutics (VRDN) | 0.1 | $7.9M | 606k | 13.01 | |
Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.1 | $7.5M | 743k | 10.06 | |
Arca Biopharma (ABIO) | 0.1 | $5.4M | 1.4M | 3.83 | |
Immunic (IMUX) | 0.1 | $5.1M | 4.6M | 1.11 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $4.9M | 125k | 39.27 | |
Acelyrin (SLRN) | 0.1 | $4.3M | 978k | 4.41 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $4.3M | 3.3M | 1.32 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $4.1M | 350k | 11.70 | |
Allurion Technologies Com Shs (ALUR) | 0.1 | $3.7M | 3.7M | 1.00 | |
Exagen (XGN) | 0.0 | $2.8M | 1.5M | 1.82 | |
Sab Biotherapeutics Com New (SABS) | 0.0 | $2.4M | 767k | 3.10 | |
Cutera (CUTR) | 0.0 | $2.0M | 1.3M | 1.51 | |
Sagimet Biosciences Com Ser A (SGMT) | 0.0 | $1.7M | 500k | 3.42 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.5M | 128k | 11.47 | |
Cytomx Therapeutics (CTMX) | 0.0 | $1.5M | 1.2M | 1.22 | |
Adicet Bio (ACET) | 0.0 | $1.3M | 1.1M | 1.21 | |
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $21k | 350k | 0.06 |